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Objective
• To examine the genome wide expression profile of differentiated THP-1 cells infected with Mycobacterium 
tuberculosis (M.tb.); upon treatment with free drugs and microparticles.
• To examine whether microparticle phagocytosis alters activation state of infected macrophages and thereby 
contributes to bactericidal activity of microparticles..
Introduction
• In pulmonary TB, inhaled bacteria colonize and proliferate within AMφ, modulating Mφ functions to 
their own advantage.
• Targeting MP directly to AMφ via inhalation therapy improves efficacy of existing drugs. (Sen et al,
PCT Int’ l Pat App. 20050084455, October 16, 2003)
• High efficacy of MP is not explicable simply on the grounds of enhanced drug delivery, in the light of 
experience with high-dose chemotherapy.
• Phagocytosis of foreign particles activates several Mφ responses, including induction of apoptosis.
• MP induce oxidative radicals and Th1 cytokines TNF-α and IL-12 in infected Mφ. (Sharma et al, 
JAC 2007)
• MP induces apoptosis in THP-1 cells infected with H37Ra which reduces bacterial load. (Yadav & 
Misra, AAC 2007)
• Apoptosis, rather than M.tb.-induced necrosis, is a legitimate host-defense strategy.
• We examined the cytokine profiles & gene expression profiles of macrophages infected with M. tb. 
H37Rv after treatments with drugs in solution, drug containing MP or blank microparticles.
•  We examined apoptosis induction in the presence or absence of caspase-3 inhibitor, caspase-3, 8 
& 9 activity in cell lysate & nitirte induction in infected macrophage treated with drugs in solution, 
microparticles or blank microparticles.
Cytokine TNF-α, IFN- , IL-2, IL-4, IL-6 and IL-10 by THP-1 cells after infection and treatment with γ
Rifabutine+Isoniazid; either soluble or as MP or blank MP for 2h.
Annexin V Staining: Fig. A. Apoptosis induction in the terms of index in THP-1 infected with H37Rv after different 
treatments. B. Apoptosis induction in the presence or absence of caspase-3 inhibitor.
Two way clustering of gene & treatments at 0, 12 
& 24 hrs time point , using Cluster and view in 
Treeview software
Caspase Activity Assay: Specific activity of caspase- 3, -8 & -9 in cell lysate after infection with H37Rv and different treatments.
Conclusions
MP treatment induces maximum  TNF-  α , IFN-   & IL-10 in infected cells MP induce maximum apoptosis γ
compared to other treatments in infected cells. Apoptosis induction was caspase dependent.
Apoptosis induction in all groups was caspase dependent except in Blank MP treated group.
MP induce maximum NO in infected or normal cells after treatments in THP-1 cells but in the case of primary 
macrophage NO induction level varied  from donor to donor. This was also true of Th1 cytokines
Bactericidal action of microparticles varied from donor to donor, in cells from one donor maximum bactericidal activity 
was observed in infected group treated with MP, in another, blank MP were able to reduce bacterial load significantly.
Microarray data on at least 2 fold up- or down- regulated genes of different groups with reference to gene expression 
by uninfected, untreated cells were clustered at different time points. 
At 0 & 24 hrs uninfected cells treated with microparticles clustered separately from all other groups, suggesting that 
the macrophage response to microparticles is concluded in 24 h in absence of infection.
At 12 hrs, gene expression profile of infected cells given any treatment clustered separately from cells given either 
infection alone or microparticles alone, suggesting that phagocytosis-induced gene expression has more in common 
than expression modulated by infection subjected to treatment.
About 1400-1700 genes were differentially regulated by different treatments. These belonged to families such as 
cytokines, chemokines, and their receptors, GPCR, transcription factors, pro- and anti-apoptotic genes, and 
housekeeping genes.
Pathway analysis of FAS and TNF-mediated apoptosis induction presented here indicates that infection alone 
downregulates pro-apoptotic pathways, while microparticles tend to either reverse this strategy or actively promote 
apoptosis induction, e.g. TRADD.
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Results
A. CFU in cell lysate B. NO estimation in THP-1 (bar) and primary macrophages (scatter)
B
Apoptosis pathway analysis using GenMAPP ( Free available software) at 
least 2 fold up or down regulated gene were considered as significant
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Experimental
Supernatants cytokines by CBA (BD); 
NO using Greiss’  Reagent
RNA ( 0, 12 & 24 hrs): Affymetrix 
HG U133 Plus 2.0 arrays; 
labeling, hybridization,  scanning 
and data analysis at TCGA, New 
Delhi.
Cell lysate: caspases by 
fluorescence assays; CFU.
Differentiated THP-1
Infected with H37Ra or H37Rv
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